<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - § 48–902.10. Schedule IV enumerated.</title>
    <meta property="st:title" content="§ 48–902.10. Schedule IV enumerated."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/reset.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/site.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/body.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <link rel="stylesheet" type="text/css" href="/css/icons/style.css" media="screen"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/9/">Chapter 9. Controlled Substances Act.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/9/subchapters/II/">Subchapter II. Standards and Schedules.</a></li>
            <li>↪ § 48–902.10. Schedule IV enumerated.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a href="/dc/council/code/sections/48-902.09.html">§ 48–902.09. Schedule IV tests.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a href="/dc/council/code/sections/48-902.11.html">§ 48–902.11. Schedule V tests.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through July 26, 2016</h3>
          <dl id="recency">
            <dt>Last codified D.C. Law:</dt>
            <dd>
          Law 21-140 effective July 26, 2016</dd>
            <dt>Last codified Emergency Law:</dt>
            <dd>
          Act 21-354 effective March 23, 2016</dd>
            <dt>Last codified Federal Law:</dt>
            <dd>
          Public Law 114-118 approved January 28, 2016</dd>
          </dl>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/sections/48-902.10.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/sections/48-902.10.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body"><h1>§ 48–902.10. Schedule IV enumerated.</h1> <section class="content"><section><section class="line-group primary-content"><p class="text-indent-1"><span class="level-num">(a)</span> The controlled substances listed in this section are included in Schedule IV, unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>:</p><p class="text-indent-2"><span class="level-num">(1)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p><p class="text-indent-3"><span class="level-num">(A)</span> Barbital;</p><p class="text-indent-3"><span class="level-num">(B)</span> Chloral betaine;</p><p class="text-indent-3"><span class="level-num">(C)</span> Chloral hydrate;</p><p class="text-indent-3"><span class="level-num">(D)</span> Chlordiazepoxide;</p><p class="text-indent-3"><span class="level-num">(E)</span> Clonazepam;</p><p class="text-indent-3"><span class="level-num">(F)</span> Clorazepate;</p><p class="text-indent-3"><span class="level-num">(G)</span> Dextropropoxyphene;</p><p class="text-indent-3"><span class="level-num">(H)</span> Diazepam;</p><p class="text-indent-3"><span class="level-num">(I)</span> Ethchlorvynol;</p><p class="text-indent-3"><span class="level-num">(J)</span> Ethinamate;</p><p class="text-indent-3"><span class="level-num">(K)</span> Flurazepam;</p><p class="text-indent-3"><span class="level-num">(L)</span> Lorazepam;</p><p class="text-indent-3"><span class="level-num">(M)</span> Mebutamate;</p><p class="text-indent-3"><span class="level-num">(N)</span> Meprobamate;</p><p class="text-indent-3"><span class="level-num">(O)</span> Methohexital;</p><p class="text-indent-3"><span class="level-num">(P)</span> Methylphenobarbital (mephobarbital);</p><p class="text-indent-3"><span class="level-num">(Q)</span> Oxazepam;</p><p class="text-indent-3"><span class="level-num">(R)</span> Paraldehyde;</p><p class="text-indent-3"><span class="level-num">(S)</span> Petrichloral;</p><p class="text-indent-3"><span class="level-num">(T)</span> Phenobarbital;</p><p class="text-indent-3"><span class="level-num">(U)</span> Prazepam;</p><p class="text-indent-3"><span class="level-num">(V)</span> Alprazolam;</p><p class="text-indent-3"><span class="level-num">(W)</span> Bromazepam;</p><p class="text-indent-3"><span class="level-num">(X)</span> Camazepam;</p><p class="text-indent-3"><span class="level-num">(Y)</span> Clobazam;</p><p class="text-indent-3"><span class="level-num">(Z)</span> Clotiazepam;</p><p class="text-indent-3"><span class="level-num">(AA)</span> Cloxazolam;</p><p class="text-indent-3"><span class="level-num">(BB)</span> Delorazepam;</p><p class="text-indent-3"><span class="level-num">(CC)</span> Estazolam;</p><p class="text-indent-3"><span class="level-num">(DD)</span> Ethyl loflazepate;</p><p class="text-indent-3"><span class="level-num">(EE)</span> Fludiazepam;</p><p class="text-indent-3"><span class="level-num">(FF)</span> Flunitrazepam;</p><p class="text-indent-3"><span class="level-num">(GG)</span> Halazepam;</p><p class="text-indent-3"><span class="level-num">(HH)</span> Haloxazolam;</p><p class="text-indent-3"><span class="level-num">(II)</span> Ketazolam;</p><p class="text-indent-3"><span class="level-num">(JJ)</span> Loprazolam;</p><p class="text-indent-3"><span class="level-num">(KK)</span> Lormetazepam;</p><p class="text-indent-3"><span class="level-num">(LL)</span> Medazepam;</p><p class="text-indent-3"><span class="level-num">(MM)</span> Midazolam;</p><p class="text-indent-3"><span class="level-num">(NN)</span> Nimetazepam;</p><p class="text-indent-3"><span class="level-num">(OO)</span> Nitrazepam;</p><p class="text-indent-3"><span class="level-num">(PP)</span> Oxazolam;</p><p class="text-indent-3"><span class="level-num">(QQ)</span> Omitted;</p><p class="text-indent-3"><span class="level-num">(RR)</span> Pinazepam;</p><p class="text-indent-3"><span class="level-num">(SS)</span> Quazepam;</p><p class="text-indent-3"><span class="level-num">(TT)</span> Temazepam;</p><p class="text-indent-3"><span class="level-num">(UU)</span> Tetrazepam;</p><p class="text-indent-3"><span class="level-num">(VV)</span> Triazolam; and</p><p class="text-indent-3"><span class="level-num">(WW)</span> Fospropofol;</p><p class="text-indent-2"><span class="level-num">(2)</span> Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible, such as Fenfluramine;</p><p class="text-indent-2"><span class="level-num">(3)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p><p class="text-indent-3"><span class="level-num">(A)</span> Diethylpropion;</p><p class="text-indent-3"><span class="level-num">(B)</span> Phentermine;</p><p class="text-indent-3"><span class="level-num">(C)</span> Pemoline (including organometallic complexes and chelates thereof);</p><p class="text-indent-3"><span class="level-num">(D)</span> Cathine;</p><p class="text-indent-3"><span class="level-num">(E)</span> Fencamfimin;</p><p class="text-indent-3"><span class="level-num">(F)</span> Fenproporex;</p><p class="text-indent-3"><span class="level-num">(G)</span> Mefenorex;</p><p class="text-indent-3"><span class="level-num">(H)</span> Pipradrol; and</p><p class="text-indent-3"><span class="level-num">(I)</span> SPA;</p><p class="text-indent-2"><span class="level-num">(4)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:</p><p class="text-indent-3"><span class="level-num">(A)</span> Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1), 2-diphenyl-1-3-methyl-2-propionoxybutane; and</p><p class="text-indent-3"><span class="level-num">(B)</span> Pentazocine; and</p><p class="text-indent-2"><span class="level-num">(5)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof of not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.</p><p class="text-indent-1"><span class="level-num">(b)</span> The Mayor may except by rule any compound, mixture, or preparation containing any depressant substance listed in paragraph (1) of subsection (a) of this section from the application of all or any part of this chapter if the compound, mixture, or preparation contains 1 or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.</p></section><br/><section class="line-group annotations"><p>
      (<a class="internal-link" href="/dc/council/laws/4-29.html#§210">Aug. 5, 1981, D.C. Law 4-29, § 210, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(e), 60 DCR 3390</a>.)
    </p><h4>Prior Codifications</h4><p>1981 Ed., § 33-520.</p><h4>Section References</h4><p>This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>.</p><h4>Effect of Amendments</h4><p>The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> added (a)(1)(WW) and made related changes; and substituted “Cathine” for “Cathine” (made no change) in (a)(3)(D).</p><h4>Emergency Legislation</h4><p>For temporary amendment of (a), see § 301(e) of the Omnibus Criminal Code Amendments Emergency Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</p><p>For temporary (90 days) amendment of this section, see § 301(e) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</p></section></section></section></section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/search.js"> </script>
  </body>
</html>
